Novartis Ag

Lts Lohmann Therapie-systeme Ag

Novartis Pharma Gmbh

Marc Riemenschnitter

Olivier Lambert

Markus Ahlheim

Michael Ausborn

Vitomir Vucenovic

The present invention relates to improved microparticles comprising a somatostatin analog, a process of making said microparticles and to pharmaceutical compositions comprising the same.

Extended-release composition comprising a somatostatin derivative in microparticles

Disclosed are microparticles comprising a somatostatin analogue embedded in a biocompatible pharmacologically acceptable polymer matrix for a long acting release and pharmaceutical compositions comprising such microparticles.

Microparticles comprising somatostatin analogues

An adhesive for medical patches or for transdermal therapeutic systems which contains a component or a combination of at least two components, such as (a) polyvinyl alcohols, (b) cellulose derivatives, (c) polyethers, (d) acid anhydrides and their acids and salts, as well as (e) non-pressure-sensitive adhesive polyacrylates. The adhesive has a tackiness which is activated and/or increased by contact with moisture or by absorption of moisture.

Growing community of inventors

Freiburg, Germany

Marc Riemenschnitter